ZVRA ZEVRA THERAPEUTICS, INC.: institutional ownership and insider trading
168 funds reported holding $714M of ZEVRA THERAPEUTICS, INC. in their latest 13F filings; in Q2 2026 funds net bought $39.8M, with 27 new positions and 17 funds selling out; over the last 12 months insiders bought $0 and sold $2.52M on the open market; over its last four quarters it reported revenue of $136M and net income of $58.3M.
ZVRA revenue and earnings
- Quarter ended Jun 30, 2026: revenue $39.7M, net income $8.75M, EPS 0.14
- Quarter ended Mar 31, 2026: revenue $36.2M, net income $37.9M, EPS 0.60
- Quarter ended Dec 31, 2025: revenue $34.1M, net income $12.2M, EPS 0.21
- Quarter ended Sep 30, 2025: revenue $26.1M, net income −$544K, EPS -0.01
Famous investors holding ZVRA
- D. E. Shaw (D. E. Shaw & Co.): $18.7M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $6.11M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $1.30M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $935K, 0.0% of the portfolio
Largest institutional holders of ZVRA
- BlackRock, Inc. (BLK) — $73.3M
- FMR LLC — $70.5M
- Woodline Partners LP — $68.6M
- VANGUARD CAPITAL MANAGEMENT LLC — $37.8M
- Caption Management, LLC — $31.9M
- VANGUARD GROUP INC — $29.6M
- Nantahala Capital Management, LLC — $25.8M
- STATE STREET CORP (STT, STT-PG) — $24.1M
- GEODE CAPITAL MANAGEMENT, LLC — $22.1M
- D. E. Shaw & Co., Inc. — $18.7M
Recent ZVRA insider trades
- Oct 12, 2026: McFarlane Neil F. sold 20,000 shares ($225K)
- Aug 14, 2026: Thompson Rahsaan sold 42,666 shares ($475K)
- Aug 10, 2026: Watton Corey Michael sold 12,300 shares ($138K)
- Jun 22, 2026: Thompson Rahsaan sold 34,557 shares ($438K)
5%+ owners
- FMR LLC: 8.3% (Schedule 13G/A, filed Aug 6, 2026)
- Woodline Partners LP: 8.1% (Schedule 13G/A, filed Aug 14, 2026)
- Vanguard Capital Management: 5.1% (Schedule 13G, filed Jul 31, 2026)
Who owns the most ZVRA stock?
The largest institutional holders of ZEVRA THERAPEUTICS, INC. in the latest 13F filings are BlackRock, Inc. (BLK) ($73.3M), FMR LLC ($70.5M), Woodline Partners LP ($68.6M).
Are insiders buying or selling ZVRA?
Over the last 12 months insiders bought $0 and sold $2.52M of ZEVRA THERAPEUTICS, INC. stock on the open market (SEC Form 4).
Which famous investors own ZVRA?
D. E. Shaw, Ken Griffin, Izzy Englander, Two Sigma.
What was ZVRA's revenue last quarter?
ZEVRA THERAPEUTICS, INC. reported revenue of $39.7M for the quarter ended June 30, 2026, with net income of $8.75M.
Which ETFs hold ZVRA?
10 ETFs and mutual funds hold it among their top 100 positions, including JSMD, XPH, SCNSX, JSML.